FIGURE 15 Additionally, examination of publication bias indicated a symmetrical distribution in the funnel plot, suggesting the absence of publication bias
Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial
mBio 10 , e0063219 (2019)
Hartman ABSTRACT BACKGROUND Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors
But then when you see the benefit of it, then he said, okay, you know what
Policy The findings support continuing the use of GLP-1 medications in women with metabolic risk factors who are considering pregnancy, says Cara Dolin, MD, a maternal-fetal medicine specialist, and a coauthor of the research, which was presented at the Society of Maternal-Fetal Medicine pregnancy meeting in February 2026